Haruko Iwase

429 total citations
21 papers, 162 citations indexed

About

Haruko Iwase is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Haruko Iwase has authored 21 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 9 papers in Obstetrics and Gynecology and 7 papers in Oncology. Recurrent topics in Haruko Iwase's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Haruko Iwase is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Haruko Iwase collaborates with scholars based in Japan and United States. Haruko Iwase's co-authors include Ken Takizawa, Toshio Takada, Hidetaka Nomura, Akiko Abe, Nobuhiro Takeshima, Kimihiko Sakamoto, Kohei Omatsu, Mikio Mikami, Takayuki Enomoto and Tsutomu Arai and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancer Letters.

In The Last Decade

Haruko Iwase

19 papers receiving 156 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruko Iwase Japan 8 106 75 39 32 24 21 162
Alaa El‐Ghobashy United Kingdom 8 70 0.7× 52 0.7× 44 1.1× 35 1.1× 22 0.9× 28 185
Barnaby Rufford United Kingdom 6 171 1.6× 103 1.4× 52 1.3× 41 1.3× 35 1.5× 12 244
Martina Delle Marchette Italy 9 148 1.4× 93 1.2× 36 0.9× 29 0.9× 25 1.0× 16 230
Deborah Neesham Australia 7 201 1.9× 153 2.0× 42 1.1× 45 1.4× 34 1.4× 15 281
Zimin Pan China 9 78 0.7× 67 0.9× 40 1.0× 62 1.9× 59 2.5× 25 235
Mareike Bommert Germany 9 181 1.7× 115 1.5× 89 2.3× 58 1.8× 22 0.9× 20 235
Piotr Sobiczewski Poland 11 161 1.5× 153 2.0× 62 1.6× 37 1.2× 50 2.1× 35 269
Giorgia Trevisan United Kingdom 7 55 0.5× 35 0.5× 44 1.1× 54 1.7× 25 1.0× 11 143
I. Belaroussi France 2 226 2.1× 90 1.2× 93 2.4× 88 2.8× 24 1.0× 2 262
Milissa U. Jones United States 4 64 0.6× 117 1.6× 25 0.6× 57 1.8× 44 1.8× 13 195

Countries citing papers authored by Haruko Iwase

Since Specialization
Citations

This map shows the geographic impact of Haruko Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruko Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruko Iwase more than expected).

Fields of papers citing papers by Haruko Iwase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruko Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruko Iwase. The network helps show where Haruko Iwase may publish in the future.

Co-authorship network of co-authors of Haruko Iwase

This figure shows the co-authorship network connecting the top 25 collaborators of Haruko Iwase. A scholar is included among the top collaborators of Haruko Iwase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruko Iwase. Haruko Iwase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoshino, Makoto, et al.. (2025). Quantification of Plasma Niraparib Using High‐Performance Liquid Chromatography in Patients With Ovarian Cancer. Biomedical Chromatography. 39(4). e70046–e70046.
2.
Yasu, Takeo, et al.. (2023). Development of a simple high-performance liquid chromatography-ultraviolet detection method for olaparib in patients with ovarian cancer. Drug Discoveries & Therapeutics. 17(6). 428–433. 1 indexed citations
3.
Ito, Mika, Osamu Yoshino, Takehiro Hiraoka, et al.. (2022). Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy. Gynecology and Minimally Invasive Therapy. 11(4). 238–241. 3 indexed citations
4.
Matsumoto, Yōko, Tetsushi Tsuruga, Mayuyo Mori‐Uchino, et al.. (2022). Manual vacuum aspiration (women's MVA) for endometrial biopsy for patients with suspected endometrial malignancies. Journal of obstetrics and gynaecology research. 48(11). 2896–2902.
5.
Matsuo, Koji, Shin Nishio, Shinya Matsuzaki, et al.. (2020). Surgical margin status and recurrence pattern in invasive vulvar Paget’s disease: A Japanese Gynecologic Oncology Group study. Gynecologic Oncology. 160(3). 748–754. 7 indexed citations
6.
Yoshino, Osamu, Yosuke Ono, Masako Honda, et al.. (2020). Relaxin-2 May Suppress Endometriosis by Reducing Fibrosis, Scar Formation, and Inflammation. Biomedicines. 8(11). 467–467. 12 indexed citations
7.
8.
Iwase, Haruko, Takeshi Hirasawa, Hidetaka Sato, et al.. (2018). The Clinical Features of Recurrent EndometrialCancer in Japan. International Journal of Gynecological Cancer. 28(8). 1616–1623. 9 indexed citations
9.
10.
Ishiyama, Hiromichi, et al.. (2015). Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy?. Journal of Radiation Research. 56(2). 354–359. 9 indexed citations
11.
Iwase, Haruko, et al.. (2015). Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. Journal of Gynecologic Oncology. 26(4). 303–303. 28 indexed citations
12.
Iwase, Haruko, Toshio Takada, Hidetaka Nomura, et al.. (2014). Clinical features of long-term survivors of recurrent epithelial ovarian cancer. International Journal of Clinical Oncology. 20(1). 143–149. 14 indexed citations
13.
Yunokawa, Mayu, Makoto Kodaira, Junichiro Hashimoto, et al.. (2014). Feasibility of Dose-Dense Paclitaxel/Carboplatin Therapy in Elderly Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer. Annals of Oncology. 25. iv311–iv311. 1 indexed citations
14.
Takada, Toshio, Haruko Iwase, Hidetaka Nomura, et al.. (2012). Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary. International Journal of Gynecological Cancer. 22(4). 573–578. 29 indexed citations
15.
Arai, Masami, et al.. (2012). [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].. PubMed. 39(4). 525–31. 5 indexed citations
16.
Hirai, Yasuo, Tomohiro Tsuchida, Toshio Takada, et al.. (2011). Stage IA Ovarian Cancers. Journal of Ultrasound in Medicine. 30(7). 943–952. 5 indexed citations
17.
Minaguchi, Takeo, Hiroyuki Yoshikawa, Shunsuke Nakagawa, et al.. (2004). Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix. Cancer Letters. 210(1). 57–62. 12 indexed citations
18.
Horii, Arata, Yosio Hiki, Akira Kanamori, et al.. (1995). [Binding of IgA1 to monocyte/macrophage cell lines (THP-1, U937) in IgA nephropathy--a possible role of O-glycan in the IgA1 molecule].. PubMed. 37(10). 558–63. 1 indexed citations
19.
Satoh, Masaaki, et al.. (1986). [A case of intracranial amelanotic melanoma].. PubMed. 38(2). 201–5. 2 indexed citations
20.
Iwase, Haruko. (1986). [Histologic analysis of microinvasive carcinoma of the cervix uteri with graphic reconstruction].. PubMed. 38(3). 393–401. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaa El‐Ghobashy Breakdown of academic impact, for papers by Barnaby Rufford Breakdown of academic impact, for papers by Martina Delle Marchette Breakdown of academic impact, for papers by Deborah Neesham Breakdown of academic impact, for papers by Zimin Pan Breakdown of academic impact, for papers by Mareike Bommert Breakdown of academic impact, for papers by Piotr Sobiczewski Breakdown of academic impact, for papers by Giorgia Trevisan Breakdown of academic impact, for papers by I. Belaroussi Breakdown of academic impact, for papers by Milissa U. Jones
Rankless by CCL
2026